arrow
T

Toshiya Tanaka

the university of tokyo
H指数:40
被引数:6,379

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Duocarmycin-Bearing Antibody-Mimetic Drug Conjugate Combined With an ATR Inhibitor Results in Complete Tumor Regression in a KPL-4 Xenograft Model

携带多卡霉素的抗体检视药物偶联物与ATR抑制剂联合应用可导致KPL-4异种移植模型中的完全肿瘤消退

2026-07-060
OAAI
Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery

可电离脂质与油酸和维生素E骨架的组合用于RNA癌症疫苗递送

2025-11-170
PRE
Neoantigen mRNA vaccines induce progenitor-exhausted T cells that support anti-PD-1 therapy in gastric cancer with peritoneal metastasis

新抗原mRNA疫苗诱导祖细胞耗竭型T细胞,支持在伴有腹膜转移的胃癌中抗PD-1疗法

2025-07-310
OAAI
Glucose-activated JMJD1A drives visceral adipogenesis via α-ketoglutarate-dependent chromatin remodeling

葡萄糖激活的JMJD1A通过α-酮戊二酸依赖的染色质重塑驱动内脏脂肪生成

2025-07-260
OA
Hepatocyte nuclear factor 4α contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9

肝细胞核因子4α 通过与GATA4和Kruppel样转录因子9协同调节1型碘甲状腺素脱碘酶基因来促进甲状腺激素稳态

2023-03-2743
OAAI
Cooperative interaction between hepatocyte nuclear factor 4α and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8

肝细胞核因子4α 和GATA转录因子之间的协同相互作用调节ATP结合盒固醇转运蛋白ABCG5和ABCG8

2023-03-2796
OAAI
The Peroxisome Proliferator-Activated Receptor γ/Retinoid X Receptor α Heterodimer Targets the Histone Modification Enzyme PR-Set7/Setd8 Gene and Regulates Adipogenesis through a Positive Feedback Loop

过氧化物酶体增殖物激活受体 γ/类维生素a X受体 α 异二聚体靶向组蛋白修饰酶PR-Set7/Setd8基因,并通过正反馈回路调节脂肪生成

2023-03-21180
OAAI
Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A

缺氧诱导因子1与KDM3A协同作用促进GLUT3 (SLC2A3) 表达的动态变化

2023-03-20203
OAAI
MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis

MYPT1-PP1β 磷酸酶对米色脂肪形成的染色质景观和共激活剂募集均呈负调控

2022-09-295
OAAI
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis

选择性ppar α 调节剂帕贝特和钠-葡萄糖协同转运蛋白2抑制剂氟列净联合治疗改善非酒精性脂肪性肝炎实验小鼠模型的组织病理学

CELLS
IF5.2
2022-02-1821
OAAI
Spatiotemporal dynamics of SETD5-containing NCoR-HDAC3 complex determines enhancer activation for adipogenesis

SETD5-containing NCoR-HDAC3复合物的时空动力学决定了脂肪生成的增强子激活

2021-12-0211
OAAI
Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content

Pemastibrate是一种选择性ppar α 调节剂,可防止非酒精性脂肪性肝炎的发展,而不会降低肝甘油三酸酯的含量

2020-05-0881
OAAI
Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2

磷酸乙醇胺积累通过下调PCYT2保护谷氨酰胺饥饿下的癌细胞

2019-10-0135
OAAI